A positive control study was conducted as parr of the ongoing validati
on program for developmental neurotoxicity testing in our laboratory u
sing a standard battery of automated systems, consisting of rotorod, m
otor activity, acoustic startle, and two-way active avoidance. Female
Sprague-Dawley rats were given 10 mg/kg diazepam (DZ) by SC injection
or 20 mg/kg methimazole (MET) by gavage from gestation day 15 (DZ) or
17 (MET) through postpartum day 10; a group of control animals remaine
d untreated. Offspring were assessed for growth, survival, development
al landmarks, and behavior. Although this study was considered useful
for obtaining historical data, it offered few advantages in terms of v
alidation of automated behavior test systems. Perinatal treatment with
DZ resulted in no maternal toxicity and no adverse effects on growth
or development of F-1 offspring; a deficit in acoustic startle respond
ing was the only behavioral effect observed. Treatment with MET result
ed in maternal toxicity, reduced neonatal body weights, and developmen
tal delays. Behavioral effects included impaired rotorod performance a
nd acoustic startle responding (neonates), and enhanced motor activity
and acoustic startle responding (young adults). However, effects on s
huttle avoidance were not observed for either drug, and only one direc
tion of behavioral effect occurred for the rotorod and motor activity
systems. These results, as well as those from subsequent studies in ou
r laboratory, suggest that it may be preferable to validate automated
behavior systems using short-term studies in which young adult animals
are treated directly with positive control agents.